vs
Brookfield Infrastructure Corp（BIPC）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是Brookfield Infrastructure Corp的1.7倍（$1.5B vs $866.0M），Steris净利率更高（12.9% vs -35.7%，领先48.6%），Steris同比增速更快（9.2% vs -4.6%）
布鲁克菲尔德基础设施合伙公司是一家公开上市的有限合伙企业，总部位于加拿大多伦多，核心业务为在全球范围内开展基础设施资产的收购、运营与管理，在全球基础设施投资领域拥有深厚的行业积累与较强的市场影响力。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
BIPC vs STE — 直观对比
营收规模更大
STE
是对方的1.7倍
$866.0M
营收增速更快
STE
高出13.8%
-4.6%
净利率更高
STE
高出48.6%
-35.7%
损益表 — Q2 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $866.0M | $1.5B |
| 净利润 | $-309.0M | $192.9M |
| 毛利率 | 65.0% | 43.8% |
| 营业利润率 | 62.7% | 18.3% |
| 净利率 | -35.7% | 12.9% |
| 营收同比 | -4.6% | 9.2% |
| 净利润同比 | -148.1% | 11.2% |
| 每股收益（稀释后） | — | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIPCSTE
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $866.0M | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $908.0M | $1.3B | ||
| Q1 24 | — | $1.1B |
净利润BIPCSTE
| Q4 25 | — | $192.9M | ||
| Q3 25 | — | $191.9M | ||
| Q2 25 | $-309.0M | $177.4M | ||
| Q1 25 | — | $145.7M | ||
| Q4 24 | — | $173.5M | ||
| Q3 24 | — | $150.0M | ||
| Q2 24 | $643.0M | $145.4M | ||
| Q1 24 | — | $-1.4M |
毛利率BIPCSTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | 65.0% | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | 63.8% | 44.7% | ||
| Q1 24 | — | 40.2% |
营业利润率BIPCSTE
| Q4 25 | — | 18.3% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | 62.7% | 17.7% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 17.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | 61.9% | 14.5% | ||
| Q1 24 | — | 22.0% |
净利率BIPCSTE
| Q4 25 | — | 12.9% | ||
| Q3 25 | — | 13.1% | ||
| Q2 25 | -35.7% | 12.8% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | 70.8% | 11.4% | ||
| Q1 24 | — | -0.1% |
每股收益（稀释后）BIPCSTE
| Q4 25 | — | $1.96 | ||
| Q3 25 | — | $1.94 | ||
| Q2 25 | — | $1.79 | ||
| Q1 25 | — | $1.48 | ||
| Q4 24 | — | $1.75 | ||
| Q3 24 | — | $1.51 | ||
| Q2 24 | — | $1.46 | ||
| Q1 24 | — | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $2.2B | $7.2B |
| 总资产 | $23.9B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资BIPCSTE
| Q4 25 | — | $423.7M | ||
| Q3 25 | — | $319.2M | ||
| Q2 25 | $1.2B | $279.7M | ||
| Q1 25 | — | $171.7M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $172.2M | ||
| Q2 24 | $466.0M | $198.3M | ||
| Q1 24 | — | $207.0M |
总债务BIPCSTE
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益BIPCSTE
| Q4 25 | — | $7.2B | ||
| Q3 25 | — | $7.0B | ||
| Q2 25 | $2.2B | $7.0B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.6B | ||
| Q2 24 | $3.5B | $6.4B | ||
| Q1 24 | — | $6.3B |
总资产BIPCSTE
| Q4 25 | — | $10.6B | ||
| Q3 25 | — | $10.4B | ||
| Q2 25 | $23.9B | $10.4B | ||
| Q1 25 | — | $10.1B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $10.2B | ||
| Q2 24 | $23.7B | $10.1B | ||
| Q1 24 | — | $11.1B |
负债/权益比BIPCSTE
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $478.0M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流BIPCSTE
| Q4 25 | — | $298.2M | ||
| Q3 25 | — | $287.8M | ||
| Q2 25 | $478.0M | $420.0M | ||
| Q1 25 | — | $260.8M | ||
| Q4 24 | — | $332.8M | ||
| Q3 24 | — | $250.7M | ||
| Q2 24 | $511.0M | $303.7M | ||
| Q1 24 | — | $254.8M |
自由现金流BIPCSTE
| Q4 25 | — | $199.5M | ||
| Q3 25 | — | $201.3M | ||
| Q2 25 | — | $326.4M | ||
| Q1 25 | — | $189.9M | ||
| Q4 24 | — | $243.6M | ||
| Q3 24 | — | $148.8M | ||
| Q2 24 | — | $195.7M | ||
| Q1 24 | — | $163.3M |
自由现金流率BIPCSTE
| Q4 25 | — | 13.3% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | 23.5% | ||
| Q1 25 | — | 12.8% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | — | 14.6% |
资本支出强度BIPCSTE
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 8.2% |
现金转化率BIPCSTE
| Q4 25 | — | 1.55× | ||
| Q3 25 | — | 1.50× | ||
| Q2 25 | — | 2.37× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | 0.79× | 2.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BIPC
暂无分部数据
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
